CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-23 | Coulie Bernard President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2021-01-23 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (right to buy) | +74,250 | 74,250 | ||
| 2021-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +73,250 | 73,250 | ||
| 2021-01-23 | Hull Hans Chief Business Officer | Grant or award · Stock Option (right to buy) | +62,250 | 62,250 | ||
| 2021-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award · Stock Option (right to buy) | +15,520 | 15,520 | ||
| 2021-01-14 | Coulie Bernard President and CEO | Sale | −2,870 | $26.20 | $75K | 467,947 |
| 2021-01-14 | Coulie Bernard President and CEO | Sale | −630 | $27.21 | $17K | 467,317 |
| 2021-01-12 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +26,573 | 26,573 | ||
| 2020-12-30 | Hull Hans Chief Business Officer | Exercise or conversion | +3,500 | $2.08 | $7K | 120,746 |
| 2020-12-30 | Hull Hans Chief Business Officer | Exercise or conversion · Stock Option (right to buy) | −3,500 | 17,479 | ||
| 2020-12-21 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +4,500 | $2.08 | $9K | 27,621 |
| 2020-12-21 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −4,500 | 190,097 | ||
| 2020-12-18 | Lefebvre Eric Chief Medical Officer | Sale | −6,788 | $26.17 | $178K | 167,792 |
| 2020-12-18 | Lefebvre Eric Chief Medical Officer | Sale | −5,712 | $26.98 | $154K | 162,080 |
| 2020-12-14 | Coulie Bernard President and CEO | Sale | −3,163 | $27.32 | $86K | 471,154 |
| 2020-12-14 | Coulie Bernard President and CEO | Sale | −337 | $27.86 | $9K | 470,817 |
| 2020-12-01 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +11,591 | $2.08 | $24K | 34,712 |
| 2020-12-01 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +7,143 | $6.22 | $44K | 41,855 |
| 2020-12-01 | Cummings Keith Lamont Chief Financial Officer | Sale | −1,139 | $28.24 | $32K | 40,716 |
| 2020-12-01 | Cummings Keith Lamont Chief Financial Officer | Sale | −1,848 | $29.07 | $54K | 38,868 |
Page 17 of 19 · 379 trades